HUMAN SKIN MAST CELL GRANULE ENZYMES--SKIN DISEASES

人体皮肤肥大细胞颗粒酶--皮肤病

基本信息

项目摘要

The goals of these studies are to isolate and characterize carboxypeptidase, a newly identified human mast cell secretory granule protease, and to localize and determine the pathobiologic role of mast cell proteolytic enzymes in mast cell mediated skin diseases. Proposed studies will address: 1) purification and physicochemical characterization of human skin mast cell carboxypeptidase; 2) characterization and in vitro reconstitution of the human skin mast cell secretory granule with respect to protease and proteoglycan components; 3) investigation of the biochemical action of purified carboxypeptidase, and enzyme- proteoglycan complexes on purified proteins, peptides, and potential cellular substrates in skin; and 4) examination of the pathobiologic role of human skin mast cell secretory granule proteases in mast cell-associated cutaneous diseases. These studies will add to understanding of the human skin mast cell, and the role of mast cell secretory granule proteases in mediating tissue damage in cutaneous disorders. To accomplish these goals, human skin mast cell carboxypeptidase, identified by an HPLC assay system, will be purified from whole skin extracts by affinity chromatography. A monospecific, polyclonal anticarboxypeptidase antibody will be developed. To understand regulation of carboxypeptidase expression, mast cells from various tissues will be assessed for carboxypeptidase activity by HPLC, and protein by ELISA or RIA, and a human mast cell cDNA library will be made to identify recombinant clones corresponding to carboxypeptidase. To understand their biochemical and biologic activity, enzyme-proteoglycan complexes from dispersed human mast cells or reconstituted from purified components, will be incubated with protein, peptide, and potential cellular substrates such as fibrinogen, laminin, substance P, angiotensin I, and cultured human umbilical vein endothelial cells, respectively. The proteolytic activity of these complexes will be examined in vitro using skin explants. The in situ release, localization and fate of carboxypeptidase will be examined in vitro using skin explants, and in vivo after intradermal injection of human C5a, and in a skin chamber model after challenge with allergens. Finally, the deposition of mast cell granule carboxypeptidase will be examined in vivo in diseases marked by increased vascular permeability, i.e. cold urticaria, and by tissue destruction, i.e. bullous pemphigoid.
这些研究的目的是分离和表征

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G.
粒细胞-血管紧张素系统。
Separation of angiotensins and assay of angiotensin-generating enzymes by high-performance liquid chromatography.
通过高效液相色谱法分离血管紧张素并测定血管紧张素生成酶。
  • DOI:
    10.1016/0003-2697(82)90329-3
  • 发表时间:
    1982
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Klickstein,LB;Wintroub,BU
  • 通讯作者:
    Wintroub,BU
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRUCE U WINTROUB其他文献

BRUCE U WINTROUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRUCE U WINTROUB', 18)}}的其他基金

HUMAN SKIN MAST CELL GRANULE ENZYMES--SKIN DISEASES
人体皮肤肥大细胞颗粒酶--皮肤病
  • 批准号:
    3156145
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
ANGIOTENSINS IN CUTANEOUS INFLAMMATION & DISEASE
血管紧张素在皮肤炎症中的作用
  • 批准号:
    3156144
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
HUMAN SKIN MAST CELL GRANULE ENZYMES: SKIN DISEASES
人类皮肤肥大细胞颗粒酶:皮肤病
  • 批准号:
    3156142
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
HUMAN SKIN MAST CELL GRANULE ENZYMES--SKIN DISEASES
人体皮肤肥大细胞颗粒酶--皮肤病
  • 批准号:
    3156146
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
HUMAN SKIN MAST CELL GRANULE ENZYMES: SKIN DISEASES
人类皮肤肥大细胞颗粒酶:皮肤病
  • 批准号:
    3156147
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
ANGIOTENSINS IN CUTANEOUS INFLAMMATION & DISEASE
血管紧张素在皮肤炎症中的作用
  • 批准号:
    3156143
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
ANGIOTENSINS IN CUTANEOUS INFLAMMATION & DISEASE
血管紧张素在皮肤炎症中的作用
  • 批准号:
    3152374
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:
BULLOUS PEMPHIGOID AND NEUTRAL PEPTIDE PATHWAY
大疱性类天疱疮和中性肽通路
  • 批准号:
    3152375
  • 财政年份:
    1982
  • 资助金额:
    $ 24.46万
  • 项目类别:

相似海外基金

PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6619530
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6787268
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6841512
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6381955
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6288357
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
PROXIMAL TUBULE ANGIOTENSINS--HEMOLYTIC UREMIC SYNDROME
近端小管血管紧张素--溶血性尿毒症综合征
  • 批准号:
    6524351
  • 财政年份:
    2000
  • 资助金额:
    $ 24.46万
  • 项目类别:
REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINS
血管紧张素对心脏肥大的调节
  • 批准号:
    6389132
  • 财政年份:
    1999
  • 资助金额:
    $ 24.46万
  • 项目类别:
REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINS
血管紧张素对心脏肥大的调节
  • 批准号:
    2761861
  • 财政年份:
    1999
  • 资助金额:
    $ 24.46万
  • 项目类别:
REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINS
血管紧张素对心脏肥大的调节
  • 批准号:
    6183555
  • 财政年份:
    1999
  • 资助金额:
    $ 24.46万
  • 项目类别:
REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINS
血管紧张素对心脏肥大的调节
  • 批准号:
    6526840
  • 财政年份:
    1999
  • 资助金额:
    $ 24.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了